Back to News
Market Impact: 0.1
Parabilis Medicines Names Former J&J Oncology Executive Craig Tendler To Board
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Parabilis Medicines (PBLS) appointed Craig L. Tendler, M.D. to its Board of Directors, continuing his role as a scientific advisor. The update is governance/oversight-focused and does not cite any new clinical, financial, or regulatory milestones.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
PBLS0.20
More News
- MSCI Ignites Indonesia Market Reckoning After Months of Warnings
- After years of U.S. export bans, China plans its own: 40 AI, chip and solar technologies could be restricted
- Indonesia’s Danantara pledges $5 billion to home-grown companies as MSCI once again threatens a downgrade
- Indonesia Caught Off Guard by Surprise MSCI Downgrade Warning
- Norway's $2 trillion wealth fund was frozen out of major defense companies. That may be about to change
- Trump’s pharma holdings surged from $1.7 million in 2024 to $56.2 million as drugmakers gained Medicare exemptions, Democrats say
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Capital IQ Alternatives for Research and Deal Work
- Research Workflows, Report Format Selection, and Interactive Synthesis